|
LOC100190938 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.122000E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.975000E-04 |
| Normal-vs-Stage2 |
1.25030000019954E-07 |
| Normal-vs-Stage3 |
1.284650E-01 |
| Normal-vs-Stage4 |
1.757840E-01 |
| Stage1-vs-Stage2 |
5.952600E-01 |
| Stage1-vs-Stage3 |
3.834800E-01 |
| Stage1-vs-Stage4 |
7.282200E-01 |
| Stage2-vs-Stage3 |
1.661400E-01 |
| Stage2-vs-Stage4 |
5.153200E-01 |
| Stage3-vs-Stage4 |
7.855400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.820200E-03 |
| Normal-vs-AfricanAmerican |
1.983020E-01 |
| Normal-vs-Asian |
7.722200E-01 |
| Caucasian-vs-AfricanAmerican |
7.850800E-01 |
| Caucasian-vs-Asian |
7.591000E-01 |
| AfricanAmerican-vs-Asian |
8.488000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.593000E-04 |
| Normal-vs-Female |
2.743200E-01 |
| Male-vs-Female |
3.779200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.984800E-01 |
| Normal-vs-Extreme_Weight |
4.79249973039941E-11 |
| Normal-vs-Obese |
2.57510013312867E-10 |
| Normal-vs-Extreme_Obese |
4.598300E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.041790E-01 |
| Normal_Weight-vs-Obese |
1.250420E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.799800E-01 |
| Extreme_Weight-vs-Obese |
6.476200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.300000E-01 |
| Obese-vs-Extreme_Obese |
6.314600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.496200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.680450E-02 |
| Normal-vs-Age(61-80Yrs) |
9.9076302717549E-12 |
| Normal-vs-Age(81-100Yrs) |
8.34410318617529E-12 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.318200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.681400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.478600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.219440E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.450200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.005400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.12796447129904E-12 |
| Normal-VS-Type2 PRCC |
3.583000E-01 |
| Normal-VS-KIRP CIMP |
1.64079860809352E-12 |
| Normal-VS-Unclassified PRCC |
6.849600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.144780E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.535980E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.294400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.815700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.011200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.634790E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.286600E-01 |
| Normal-vs-N1 |
2.230800E-01 |
| Normal-vs-N2 |
7.306100E-02 |
| N0-vs-N1 |
7.027200E-01 |
| N0-vs-N2 |
6.038000E-01 |
| N1-vs-N2 |
8.557000E-01 |
|
|
